Ballentine Partners LLC Sells 2,975 Shares of Cigna Group $CI

Ballentine Partners LLC decreased its holdings in shares of Cigna Group (NYSE:CI) by 31.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,553 shares of the health services provider’s stock after selling 2,975 shares during the period. Ballentine Partners LLC’s holdings in Cigna Group were worth $1,804,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of the business. OLD National Bancorp IN grew its position in shares of Cigna Group by 3.7% during the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock valued at $284,000 after acquiring an additional 37 shares during the period. Leavell Investment Management Inc. raised its position in shares of Cigna Group by 3.8% during the 3rd quarter. Leavell Investment Management Inc. now owns 1,103 shares of the health services provider’s stock valued at $318,000 after purchasing an additional 40 shares during the period. Physician Wealth Advisors Inc. raised its position in shares of Cigna Group by 1.5% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider’s stock valued at $782,000 after purchasing an additional 41 shares during the period. Cookson Peirce & Co. Inc. raised its position in shares of Cigna Group by 0.8% during the 3rd quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock valued at $1,428,000 after purchasing an additional 41 shares during the period. Finally, Signet Financial Management LLC raised its position in shares of Cigna Group by 0.6% during the 3rd quarter. Signet Financial Management LLC now owns 7,459 shares of the health services provider’s stock valued at $2,150,000 after purchasing an additional 41 shares during the period. Institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on CI. Robert W. Baird set a $337.00 price objective on shares of Cigna Group in a research report on Friday, May 1st. Jefferies Financial Group decreased their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. TD Cowen raised their price objective on shares of Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, February 9th. Guggenheim raised their price objective on shares of Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research report on Tuesday, February 10th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $338.35.

Insider Activity at Cigna Group

In related news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares in the company, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Stock Performance

Cigna Group stock opened at $288.01 on Friday. The company’s 50-day moving average price is $274.29 and its 200-day moving average price is $276.32. Cigna Group has a twelve month low of $239.51 and a twelve month high of $338.89. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a market cap of $76.19 billion, a PE ratio of 12.21, a price-to-earnings-growth ratio of 1.01 and a beta of 0.30.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same period in the previous year, the firm posted $6.74 EPS. The business’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities research analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio is presently 26.45%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.